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Abstract Mammalian cells are characterized by an endomem-
brane system. Nevertheless, some cells lose these membranes
during their terminal differentiation, e.g. red blood cells and lens
fiber cells of the eye. 15-Lipoxygenase is believed to be critical
for this membrane degradation. Here we use cultivated rabbit
reticulocytes in the presence or absence of a lipoxygenase
inhibitor to provide further evidence for the importance of 15-
lipoxygenase for the in vivo degradation of mitochondria. We
find that inhibitor treatment retarded mitochondrial degradation,
as shown by persistence of marker proteins and by direct
visualization of mitochondria by electron microscopy. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
One of the hallmarks of reticulocyte maturation is the deg-
radation of the cell’s organelles, the most abundant of which
are mitochondria. Several degradation mechanisms have been
proposed, most prominently autophagy [1] and cytosolic deg-
radation [2]. 15-Lipoxygenase (15-LOX) has been proposed to
take part in cytosolic organelle degradation in the reticulocyte
[3]. The enzyme has recently been found to integrate speci¢-
cally into organelle membranes, but not into the plasma mem-
brane [4,5]. It thus permeabilizes organelles and creates access
for the cytosolic proteolytic machinery, consisting mainly of
the ubiquitin/proteasome system [6^8]. 15-LOX is only present
at the reticulocyte stage of red blood cell maturation; until
then 15-LOX mRNA is translationally inhibited by proteins
binding to its 3P-UTR [9]. At the reticulocyte stage, however,
very large amounts of 15-LOX (up to 4 mg/ml of packed cells
during experimental anemia) can be detected.
All of the aforementioned ¢ndings indicate that 15-LOX is
in a perfect position to initiate the organelle degradation pro-
cess. To establish whether the degradation of organelles dur-
ing reticulocyte maturation is in fact lipoxygenase-dependent,
we have cultured a reticulocyte-rich blood cell suspension in
the presence or absence of the lipoxygenase inhibitor eicosa-
tetraynoic acid (ETYA). ETYA is a dual-speci¢city inhibitor,
a¡ecting both lipoxygenases and cyclooxygenases. However,
since no cyclooxygenases are present and the 15-LOX is the
only lipoxygenase in the reticulocyte, this should not pose a
problem in interpreting the results of our study. Previous
studies utilizing lipoxygenase inhibitors have been restricted
by detecting only amino acid release as a measure of overall
proteolysis [10] or have only followed a single enzyme activity
[11]. We have decided to use a more stringent approach in-
cluding electron microscopy and Western blot analysis. We
have found the inhibitor to diminish, but not to totally abro-
gate the organelle degradation process, supporting the concept
that 15-LOX is a key enzyme in the cytosolic degradation of
organelles during reticulocyte maturation. In addition to this
cytosolic degradation, disposal of organelles via autophagic
vacuoles occurs in parallel.
2. Materials and methods
Rabbits were made anemic by subcutaneous injection of phenyl-
hydrazine (three doses of 12.5 mg/kg) according to Jackson and
Hunt [12]. This protocol led to a decrease in cell number to about
25^40% of the non-anemic animal (0.8^2U109/ml vs. 4^6U109/ml).
On day 8, rabbits were anesthetized by injection of ketamine/xylazine
and intravenous injection of 2000 U of heparin prior to bleeding by
heart puncture in accordance with the institutional animal protocol.
To prevent clotting during incubation of the blood obtained, an addi-
tional 40 U of heparin was added per ml of blood. For incubation, the
blood was diluted 1:20 in RPMI 1640 supplemented with 5% fetal
bovine serum and incubated at 37‡C in 6-well dishes (Nunclon) for
periods of up to 72 h. ETYA dissolved in dimethyl sulfoxide (DMSO)
was added at a ¢nal concentration of 100 WM; this relatively high
concentration of inhibitor was deemed necessary because of the enor-
mous abundance of 15-LOX in the reticulocyte (overall cellular con-
centration around 50 WM). As a control an equal amount of DMSO
(¢nal concentration 0.3%) was added to parallel incubations. At the
time points indicated, blood cells from individual wells were collected
and processed as indicated below. Similar results to those presented
here were obtained when other lipoxygenase inhibitors such as escu-
letin and salicyl hydroxamic acid were used (not shown).
Cell number and percentage of cells hemolyzed were determined for
each sample. Only samples with less than 15% hemolysis, as judged by
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absorption at 550 nm of a cell supernatant after centrifugation, were
further analyzed. The percentage of reticulocytes in each sample was
determined according to the manufacturer’s protocol in a FACScan
analyzer (Becton-Dickinson) after staining for RNA with thiazole
orange. Typically, the samples contained between 35 and 60% retic-
ulocytes at the time of bleeding. This value declined to about 10%
after 72 h of incubation. To prepare samples for electron microscopy,
1 ml sample (corresponding to 50 Wl blood) was spun down in an
Eppendorf centrifuge for 5 min at 5000 rpm. The pellet was resus-
pended in 1 ml freshly prepared 1% glutaraldehyde/0.1 M Na-caco-
dylate pH 7.5 and kept on ice for 20 min. After centrifuging for 5 min
at 5000 rpm, the pellet was then washed with 0.1 M Na-cacodylate
and resuspended in 30% sucrose/30% ethylene glycol/0.1 M Na-phos-
phate pH 7.5. Pellets were dehydrated with an ethanol series, in¢l-
trated with increasing ratios of araldite 502 and Embed 812 resin
(Electron Microscopy Sciences) to propylene oxide solvent, and the
resin was left to harden at 60‡C for 2 days. Ultrathin sections (0.7 Wm)
were cut, £oated onto grids and counterstained with lead citrate and
uranyl acetate. Photomicrographs of all cells containing organelles or
some internal structure were taken on a JEOL Temscan 100CX-II
microscope.
To prepare samples for analysis by Western blotting, red blood cells
were isolated by spinning the sample through 6 ml of Ficoll-Paque
(Pharmacia) for 30 min at 1500 rpm. The red cell pellet was washed
once with phosphate-bu¡ered saline (PBS) and then hemolyzed by
addition of 2.5 ml distilled H2O. The membrane fraction containing
unbroken cells, plasma membranes and organelles was collected by
centrifugation for 15 min at 100 000 rpm in a TLA 100.4 rotor (Beck-
man). The supernatant was precipitated at 66% ammonium sulfate to
remove most of the hemoglobin, recombined with the pellet fraction,
and analyzed by Western blotting for mitochondrial marker proteins.
After sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE), organelle marker proteins were detected by ECL de-
tection (Amersham). To measure the membrane permeabilizing ca-
pacity of 15-LOX contained in the cytosolic fraction aliquots of the
ammonium sulfate precipitated supernatants were incubated with eth-
ylenediaminetetraacetate (EDTA)-high salt washed dog pancreas mi-
crosomes for 2 h at 37‡C. A control incubation was carried out in the
presence of bu¡er. The membranes were re-isolated by centrifugation
through a 0.5-M sucrose cushion and aliquots of pellet and super-
natant fractions were analyzed for content of the lumenal endoplasmic
reticulum (ER) protein disul¢de isomerase (PDI) by SDS^PAGE and
Western blotting.
3. Results
3.1. The lipoxygenase fraction from reticulocytes cultured
in the presence of ETYA no longer permeabilizes
ER membranes
One prerequisite for studying the e¡ect of lipoxygenase in-
hibitors on organelle degradation is to ascertain the e¡ective-
ness of the drug at inhibiting 15-LOX in the cellular setting.
Taking advantage of the fact that ETYA is an irreversible
inhibitor, we therefore isolated a cytosolic fraction from cells
incubated in the presence or in the absence of inhibitor at
various time points and assayed the activity of the lipoxygen-
ase in vitro according to van Leyen et al. [4]. At each time
point up to 72 h, the lipoxygenase from cells cultured in the
absence of inhibitor was able to permeabilize ER membranes,
as indicated by release of the lumenal ER protein PDI into the
supernatant. In contrast, utilizing the lipoxygenase from cells
cultured in the presence of inhibitor greatly diminished this
release (Fig. 1). This result demonstrates that ETYA e¡ec-
tively inhibits 15-LOX when added to cultured cells. On the
other hand, as a negative control erythrocyte lysate is inactive
in this assay (M. Wiedmann, unpublished).
3.2. Morphology of reticulocytes cultured in vitro
In order to follow the reticulocyte maturation process, we
analyzed the blood cells on the ultrastructural level. The per-
centage of reticulocytes at the time of bleeding, measured by
RNA staining in a FACScan analyzer, typically ranged from
30 to 60% (data not shown). Moreover, the reticulocytes
among these cells can be expected to be in various matura-
tional stages, with early reticulocytes containing a multitude
of organelles while later maturational stages are devoid of
organelles. Previous studies have shown that these late retic-
ulocytes cannot be readily di¡erentiated from erythrocytes
under the transmission electron microscope [13^15]. Conse-
quently, when analyzed by electron microscopy, most cells
exhibited a non-structured cytosol, indicating they are either
erythrocytes or medium- to late-stage reticulocytes. Nucleated
cells were only very rarely detected, re£ecting the predomi-
nance of red cells over leukocytes. When organelles were
found in non-nucleated cells (Fig. 2A^D), these were mostly
mitochondria (M in Fig. 2A,B) and vacuoles (V in Fig. 2B^
D), many of which contained organelle remnants. In addition,
numerous ribosomes and polyribosomes were visible (small
dark spots in Fig. 2C,D). Some siderosomes were also present
(S in Fig. 2A,C).
After 48 h of culture in the absence of a lipoxygenase in-
hibitor, practically all cells exhibited the non-structured cyto-
sol characteristic of late reticulocytes and erythrocytes, re£ect-
ing the in vitro maturation of these cells. In the rare cases
where subcellular structures were visible (Fig. 2E^H), these
were late-stage vacuoles either devoid of content (Fig.
2G,H) or containing severely damaged organellar remnants
(Fig. 2E^H). No mitochondria or mitochondrial remnants
could be detected in the cytosol. Also, no ribosomes or poly-
ribosomal assemblies were visible, indicating the advanced
maturational stage of these cells [16,17]. These ¢ndings corre-
spond well to those of Steck and colleagues [14], who reported
an e¡ective maturation of rat reticulocytes cultured in vitro.
In contrast, when cultured in the presence of ETYA, cells
containing recognizable mitochondria could still readily be
detected (Fig. 2I,J,K). Autophagic vacuoles containing organ-
elles in various stages of degradation were also present (Fig.
2K,L). A number of these vacuoles contained mitochondria
that appeared to be only mildly damaged. This could re£ect
an inhibition of the autophagic degradation pathway; alter-
Fig. 1. 15-LOX isolated from reticulocytes cultured in the presence
of ETYA can no longer permeabilize ER membranes. Lipoxygenase
containing samples were prepared from the red cell fractions at the
time points indicated according to Section 2 and incubated with
EDTA-high salt washed dog pancreas microsomes. Control incuba-
tions were carried out in the presence of bu¡er (None) and with
lipoxygenase containing fraction from freshly isolated blood cells
(0h). After pelleting the membranes, aliquots of pellet (P) and
supernatant (S) fractions were probed for PDI, a lumenal ER pro-
tein, by SDS^PAGE and Western blotting. While the lipoxygenase
contained in the supernatant fractions of cells incubated in the ab-
sence of lipoxygenase inhibitor is capable of permeabilizing ER
membranes, the lipoxygenase from the inhibitor-treated cells leads
to very little release of the marker protein, indicating inactivation of
the lipoxygenase by ETYA.
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natively, these mitochondria may have only recently been tak-
en up into a vacuole. At the same time, ribosomes and poly-
ribosomes were absent. This demonstrates that the lipoxygen-
ase inhibitor in£uenced only mitochondrial degradation
without a¡ecting other aspects of the maturation process.
3.3. Western blot analysis of red cells after incubation in the
presence or absence of ETYA
The morphology of the cultured reticulocytes served as an
indication that organelle degradation, and speci¢cally that of
mitochondria, is slowed down considerably when the cells are
incubated in the presence of a lipoxygenase inhibitor. In order
to determine the signi¢cance of these ¢ndings for individual
proteins, we decided to analyze the cells for the presence of
mitochondrial proteins by Western blotting. For this, the red
blood cell fraction had to be isolated by centrifugation
through a Ficoll cushion in order to eliminate leukocytes,
which, despite their relatively low abundance in peripheral
blood (ca. 0.1%) would falsify results owing to their large
number of mitochondria. Samples at di¡erent time points
were then probed with antibodies to mitochondrial marker
proteins. Methylmalonyl coenzyme A mutase (MMCoAMu-
tase) localizes to the mitochondrial matrix, while cytochrome
c is localized in the intermembrane space. For both proteins,
Western blotting of lysates from cells incubated in the absence
of lipoxygenase inhibitor showed a rapid time-dependent de-
cline of the signal, as could be expected from the electron
micrographs. The residual signal apparent after 72 h could
be due either to the proteins persisting after the organelle
that once contained them has been degraded, or to contami-
nating residual leukocytes. In the cells incubated in the pres-
ence of the lipoxygenase inhibitor, the ECL signal for both
proteins declined only slightly, indicating that the degradation
of these proteins is delayed.
4. Discussion
We have analyzed the process of programmed organelle
degradation in cultured reticulocytes. Analysis of control cul-
tures by electron microscopy shows that after 48 h of incuba-
tion, no intact mitochondria can be detected on the ultrastruc-
tural level, and most cells exhibit the non-structured cytosol
characteristic of late reticulocytes and mature erythrocytes.
Occasionally, vacuoles with and without organellar remnants
can be seen (Fig. 2E^H). These indicate that our cultured
reticulocytes undergo a normal maturation process as charac-
Fig. 3. Western blot analysis of red cells after incubation in the
presence or absence of ETYA. After incubation for the times indi-
cated, red cells were isolated by Ficoll separation to remove white
blood cells and analyzed by Western blotting for mitochondrial
marker proteins. Cytochrome c localizes to the intermembrane
space, while MMCoAMutase is a matrix protein. Both proteins are
degraded more rapidly in the cells incubated in the absence of
ETYA, indicating a protective e¡ect of ETYA towards mitochon-
dria.
Fig. 2. Morphology of reticulocytes cultured in vitro. Blood cells
were analyzed by electron microscopy to study the morphology of
the reticulocytes obtained. Cells exhibiting some internal structure,
indicating they are not erythrocytes, were selected under the electron
microscope. A^D: Cells freshly isolated, prior to incubation. Besides
mitochondria (M) and autophagic vacuoles (V), these cells also con-
tained siderosomes (S). In C and D, ribosomes and polyribosomes
are visible as electron-dense spots. E^H: Cells after 48 h incubation
in the absence of lipoxygenase inhibitor. No mitochondria were de-
tected, but vacuoles in some cases persisted. I^L: Cells after 48 h
incubation in the presence of the lipoxygenase inhibitor ETYA. Cy-
tosolic mitochondria as well as mitochondria enclosed in vacuoles
are visible. Scale bar: 1 Wm.
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terized in previous studies [14,18]. The process of reticulocyte
maturation is also re£ected in the time-dependent disappear-
ance of the mitochondrial proteins, MMCoAMutase and cy-
tochrome c (Fig. 3). In this case, low levels of these proteins
persist even after 72 h, indicating the degradation process
continues after the organelle itself has vanished. It is generally
believed that reticulocyte maturation in the bloodstream oc-
curs within 48 h [19]. Although this is supported by our ultra-
structural ¢ndings, our Western blotting results indicate that
full maturation, measured by protein turnover may not be
completed within this time span. Conversely, this may re£ect
di¡erences in the maturation process of reticulocytes in cul-
ture or in the live animal.
In the presence of ETYA, a lipoxygenase inhibitor, the
organelle degradation process is delayed, consistent with the
proposed function of the cytosolic 15-LOX in programmed
organelle degradation. Since 15-LOX is no longer active under
these conditions, the cytosolic pathway for disposal of organ-
elles is disrupted, and relatively intact mitochondria can still
be detected in the cytosol after 48 h of culture. In some cells,
autophagic vacuoles containing mitochondria and mitochon-
drial remnants can also be observed. Since the lipoxygenase
inhibitor would not be expected to inhibit this pathway, this
presumably explains why some organelle degradation, and
also some degradation of cytochrome c and MMCoAMutase,
still occurs. It is likely that these mechanisms operate in par-
allel, providing for a backup system. The existence of two
parallel pathways for organelle degradation may be the reason
why mice in which the gene for the leukocyte-type 12-LOX
(the presumed mouse orthologue of the 15-LOX-1 gene of
rabbits and humans) has been disrupted do not exhibit gross
abnormalities in their blood cells [20]. Our ¢ndings demon-
strate that the cytosolic lipoxygenase pathway for organelle
degradation is a major, but not the only means of organelle
disposal in the reticulocyte.
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